α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial-Reference-Cited by-同舟云学术

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Published:2012-12 Issue:1 Volume:12 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Akiyama Yasuto,Oshita Chie,Kume Akiko,Iizuka Akira,Miyata Haruo,Komiyama Masaru,Ashizawa Tadashi,Yagoto Mika,Abe Yoshiaki,Mitsuya Koichi,Watanabe Reiko,Sugino Takashi,Yamaguchi Ken,Nakasu Yoko

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-12-623.pdf

Reference36 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352 (10): 987-996. 10.1056/NEJMoa043330.

2. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, et al: Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006, 24 (16): 2563-2569. 10.1200/JCO.2005.04.5963.

3. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K: Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell. 2009, 5 (5): 504-514. 10.1016/j.stem.2009.08.018.

4. McFarland BC, Ma JY, Langford CP, Gillespie GY, Yu H, Zheng Y, Nozell SE, Huszar D, Benveniste EN: Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther. 2011, 10 (12): 2384-2393. 10.1158/1535-7163.MCT-11-0480.

5. Sai K, Wang S, Balasubramaniyan V, Conrad C, Lang FF, Aldape K, Szymanski S, Fokt I, Dasgupta A, Madden T, et al: Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. J Neurooncol. 2012, 107 (3): 487-501. 10.1007/s11060-011-0786-z.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma;Frontiers in Immunology;2023-10-20

2. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements;International Journal of Molecular Sciences;2023-10-10

3. Human dendritic cell subsets in the glioblastoma-associated microenvironment;Journal of Neuroimmunology;2023-10

4. Dendritic cell vaccine trials in gliomas: Untangling the lines;Neuro-Oncology;2023-06-08

5. Immunotherapy associated central nervous system complications in primary brain tumors;Frontiers in Oncology;2023-02-16